Here, we sought to explore the effect of ICIs nivolumab and epacadostat on the behavior of natural killer (NK), CD4+, and CD8+ T cells in the presence of HPV-negative HNSCC cells. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.